An interview with Dr. Kimberly Allison from Stanford University School of Medicine and Dr. Antonio Wolff from Johns Hopkins University on "Estrogen and Progesterone Receptor Testing in Breast Cancer ...

A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-estrogen treatment for women with breast cancer, a new Cambridge-led trial has found. A low ...

Women using a certain type of hormone therapy to treat menopause symptoms could be at higher risk for breast cancer, according to a new study. The study, published Tuesday in The Lancet Oncology, ...

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study) A deeper look reveals a ...

For millions of American women, hormone replacement therapy (HRT) has provided relief from side effects of menopause. As the ovaries stop releasing eggs, a woman’s body also stops producing the ...

The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminising hormone therapy. This is demonstrated by an ...

Progesterone is part of hormone replacement therapy (HRT) for people who have been through menopause and still have a uterus. Possible side effects include spotting, headaches, and breast tenderness.

Menopause brings a lot of change, and it’s normal to feel uncertain about what’s happening in your body. Two of the most important hormone players in this transition are estrogen and progesterone.

The addition of the hormone progesterone to gender-affirming hormone therapy leads to increased breast growth for transgender people following feminizing hormone therapy. This is demonstrated by an ...